The differences between ICL repair during and outside of S phase

Trends in Biochemical Sciences

Volumn 38, Issue 8, 2013, Pages 386-393

  Williams, Hannah L ^a   Gottesman, Max E ^a   Gautier, Jean ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BRCA2 PROTEIN; CISPLATIN; DNA DIRECTED DNA POLYMERASE ETA; DNA DIRECTED DNA POLYMERASE GAMMA; DNA POLYMERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA PROTEIN; HISTONE H2AX; MITOMYCIN; PROTEIN FANCI; PROTEIN FANCJ; PROTEIN FANCM; RAD51 PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

CANCER RESISTANCE; CELL CYCLE S PHASE; DNA CROSS LINKING; DNA END JOINING REPAIR; DNA HELIX; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; DRUG SENSITIVITY; FANCONI ANEMIA; GENE MUTATION; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; HUMAN; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSCRIPTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; HUMANS; MODELS, BIOLOGICAL; RECOMBINATIONAL DNA REPAIR; S PHASE;

EID: 84880724636     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2013.05.004     Document Type: Review

References (90)

1. Summerfield F.W., Tappel A.L. Detection and measurement by high-performance liquid chromatography of malondialdehyde crosslinks in DNA. Anal. Biochem. 1984, 143:265-271.
2. Summerfield F.W., Tappel A.L. Cross-linking of DNA in liver and testes of rats fed 1,3-propanediol. Chem. Biol. Interact. 1984, 50:87-96.
3. Smeaton M.B., et al. Distortion-dependent unhooking of interstrand cross-links in mammalian cell extracts. Biochemistry 2008, 47:9920-9930.
4. Rink S.M., Hopkins P.B. A mechlorethamine-induced DNA interstrand cross-link bends duplex DNA. Biochemistry 1995, 34:1439-1445.
5. Tomasz M., et al. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 1987, 235:1204-1208.
6. Roberts J.J., Friedlos F. Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: relationship to toxicity. Pharmacol. Ther. 1987, 34:215-246.
7. Noll D.M., et al. Formation and repair of interstrand cross-links in DNA. Chem. Rev. 2006, 106:277-301.
8. Guainazzi A., Scharer O.D. Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy. Cell. Mol. Life Sci. 2010, 67:3683-3697.
9. Wang L.C., Gautier J. The Fanconi anemia pathway and ICL repair: implications for cancer therapy. Crit. Rev. Biochem. Mol. Biol. 2010, 45:424-439.
10. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
11. Sasaki M.S., Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 1973, 33:1829-1836.
12. Muniandy P.A., et al. Repair of laser-localized DNA interstrand cross-links in G1 phase mammalian cells. J. Biol. Chem. 2009, 284:27908-27917.
13. De Silva I.U., et al. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol. 2000, 20:7980-7990.
14. Wang X., et al. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol. Cell. Biol. 2001, 21:713-720.
15. Zheng H., et al. Nucleotide excision repair- and polymerase η-mediated error-prone removal of mitomycin C interstrand cross-links. Mol. Cell. Biol. 2003, 23:754-761.
16. Enoiu M., et al. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res. 2012, 40:8953-8964.
17. Zhang N., et al. hMutSβ is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. Cell. Biol. 2002, 22:2388-2397.
18. Ben-Yehoyada M., et al. Checkpoint signaling from a single DNA interstrand crosslink. Mol. Cell 2009, 35:704-715.
19. Hlavin E.M., et al. Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells. Biochemistry 2010, 49:3977-3988.
20. Räschle M., et al. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 2008, 134:969-980.
21. Ciccia A., et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 2007, 25:331-343.
22. Yan Z., et al. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol. Cell 2010, 37:865-878.
23. Singh T.R., et al. MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol. Cell 2010, 37:879-886.
24. Kim J.M., et al. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 2008, 111:5215-5222.
25. Gari K., et al. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16107-16112.
26. Singh T.R., et al. Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood 2009, 114:174-180.
27. Rosado I.V., et al. The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but is dispensable for DNA crosslink repair. Nucleic Acids Res. 2009, 37:4360-4370.
28. Wang Y., et al. FANCM and FAAP24 maintain genome stability via cooperative as well as unique functions. Mol. Cell 2013, 49:997-1009.
29. Huang M., et al. Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi anemia pathway. DNA Repair (Amst.) 2011, 10:1203-1212.
30. Williams S.A., et al. Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum. Mol. Genet. 2011, 20:4395-4410.
31. Aquilina G., et al. N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 1998, 58:135-141.
32. Fiumicino S., et al. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts. Int. J. Cancer 2000, 85:590-596.
33. Wu Q., et al. Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep. 2005, 6:551-557.
34. Barber L.J., et al. DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. Mol. Cell. Biol. 2005, 25:2297-2309.
35. Ward T.A., et al. Components of a Fanconi-like pathway control Pso2-independent DNA interstrand crosslink repair in yeast. PLoS Genet. 2012, 8:e1002884.
36. Larminat F., et al. Gene-specific DNA repair of interstrand cross-links induced by chemotherapeutic agents can be preferential. J. Biol. Chem. 1993, 268:2649-2654.
37. Islas A.L., et al. Differential introduction and repair of psoralen photoadducts to DNA in specific human genes. Cancer Res. 1991, 51:2867-2873.
38. Williams H.L., et al. Replication-independent repair of DNA interstrand crosslinks. Mol. Cell 2012, 47:140-147.
39. Zhao J., et al. Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks. Nucleic Acids Res. 2009, 37:4420-4429.
40. Thoma B.S., et al. Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks. Nucleic Acids Res. 2005, 33:2993-3001.
41. Vasquez K.M., et al. Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:5848-5853.
42. Camenisch U., et al. Two-stage dynamic DNA quality check by xeroderma pigmentosum group C protein. EMBO J. 2009, 28:2387-2399.
43. Maillard O., et al. An aromatic sensor with aversion to damaged strands confers versatility to DNA repair. PLoS Biol. 2007, 5:e79.
44. Coste F., et al. Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site. Nucleic Acids Res. 1999, 27:1837-1846.
45. Spielmann H.P., et al. Solution structures of psoralen monoadducted and cross-linked DNA oligomers by NMR spectroscopy and restrained molecular dynamics. Biochemistry 1995, 34:12937-12953.
46. Camenisch U., et al. Recognition of helical kinks by xeroderma pigmentosum group A protein triggers DNA excision repair. Nat. Struct. Mol. Biol. 2006, 13:278-284.
47. Hoy C.A., et al. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res. 1985, 45:1737-1743.
48. Andersson B.S., et al. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother. Pharmacol. 1996, 38:406-416.
49. De Silva I.U., et al. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. Nucleic Acids Res. 2002, 30:3848-3856.
50. Niedernhofer L.J., et al. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol. Cell. Biol. 2004, 24:5776-5787.
51. Bergstralh D.T., Sekelsky J. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?. Trends Genet. 2008, 24:70-76.
52. Wang A.T., et al. Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev. 2011, 25:1859-1870.
53. Kim Y., et al. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 2011, 43:142-146.
54. Fekairi S., et al. Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell 2009, 138:78-89.
55. Kim Y., et al. Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4. Blood 2013, 121:54-63.
56. Yamamoto K.N., et al. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:6492-6496.
57. Hanada K., et al. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 2006, 25:4921-4932.
58. Kratz K., et al. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 2010, 142:77-88.
59. MacKay C., et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010, 142:65-76.
60. Smogorzewska A., et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 2010, 39:36-47.
61. Fisher L.A., et al. Processing of a psoralen DNA interstrand cross-link by XPF-ERCC1 complex in vitro. J. Biol. Chem. 2008, 283:1275-1281.
62. Kuraoka I., et al. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 2000, 275:26632-26636.
63. Knipscheer P., et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 2009, 326:1698-1701.
64. Shen X., et al. Recruitment of Fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Mol. Cell 2009, 35:716-723.
65. Berardini M., et al. DNA polymerase II (polB) is involved in a new DNA repair pathway for DNA interstrand cross-links in Escherichia coli. J. Bacteriol. 1999, 181:2878-2882.
66. Wu F., et al. DNA polymerase ζ regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res. 2004, 64:8029-8035.
67. Okada T., et al. Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol. Cell. Biol. 2005, 25:6103-6111.
68. Sonoda E., et al. Multiple roles of Rev3, the catalytic subunit of polζ in maintaining genome stability in vertebrates. EMBO J. 2003, 22:3188-3197.
69. Wittschieben J.P., et al. Loss of DNA polymerase ζ causes chromosomal instability in mammalian cells. Cancer Res. 2006, 66:134-142.
70. Simpson L.J., Sale J.E. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 2003, 22:1654-1664.
71. Murakumo Y., et al. Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J. Biol. Chem. 2001, 276:35644-35651.
72. Sarkar S., et al. DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase ζ. EMBO J. 2006, 25:1285-1294.
73. Shen X., et al. REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J. Biol. Chem. 2006, 281:13869-13872.
74. Ogi T., et al. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol. Cell 2010, 37:714-727.
75. Mogi S., et al. DNA polymerase η reduces the γ-H2AX response to psoralen interstrand crosslinks in human cells. Exp. Cell Res. 2008, 314:887-895.
76. Ho T.V., et al. Structure-dependent bypass of DNA interstrand crosslinks by translesion synthesis polymerases. Nucleic Acids Res. 2011, 39:7455-7464.
77. Hinz J.M., et al. The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair (Amst.) 2006, 5:875-884.
78. Papadopoulo D., et al. Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. Prog. Clin. Biol. Res. 1990, 340A:241-248.
79. Niedzwiedz W., et al. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 2004, 15:607-620.
80. Kim H., et al. Regulation of Rev1 by the Fanconi anemia core complex. Nat. Struct. Mol. Biol. 2012, 19:164-170.
81. Bhattacharyya A., et al. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J. Biol. Chem. 2000, 275:23899-23903.
82. Grossmann K.F., et al. S. cerevisiae has three pathways for DNA interstrand crosslink repair. Mutat. Res. 2001, 487:73-83.
83. Moynahan M.E., et al. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 2001, 61:4842-4850.
84. Kraakman-van der Zwet M., et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 2002, 22:669-679.
85. Pace P., et al. Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science 2010, 329:219-223.
86. Bunting S.F., et al. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol. Cell 2012, 46:125-135.
87. Nakanishi K., et al. Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication. Nat. Struct. Mol. Biol. 2011, 18:500-503.
88. Long D.T., et al. Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science 2011, 333:84-87.
89. Enoiu M., et al. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acid Res. 2012, 40:8953-8964.
90. Grillari J., et al. Contributions of DNA interstrand cross-links to aging of cells and organisms. Nucleic Acids Res. 2007, 35:7566-7576.